SETD2 Mutations in Prognosis and Chemotherapy Resistance in Relapsed Acute Lymphoblastic Leukemia |
Dana-Farber Cancer Institute / Brenton Mar, MD, PhD |
Young Investigator Grants |
2014 |
Massachusetts |
Serious Morbidity and Financial Outcomes Among Pediatric Cancer Survivors |
Fred Hutchinson Cancer Research Center / Beth Mueller, PhD |
Epidemiology Grants |
2014 |
Washington |
Role of LMO1 in Neuroblastoma Initiation and Maintenance: Analysis in the Zebrafish model of Childhood Neuroblastoma |
Dana-Farber Cancer Institute / Thomas Look, M.D. |
Innovation Grants |
2014 |
Massachusetts |
Phase I Trial of Indoximod in Combination with Temozolomide-based Therapy for Children with Progressive Primary Brain Tumors |
Georgia Health Sciences University Research Institute, Inc. / Theodore Johnson, M.D., Ph.D. |
Bio-Therapeutic Impact Award |
2014 |
Georgia |
Perinatal Hormonal Biomarkers and Risk of Testicular Germ Cell Tumors |
University of California Berkeley / Catherine Metayer, MD, PhD |
Epidemiology Grants |
2014 |
California |
Pediatric Oncology Nurses' Experiences with Prognosis-Related Communication |
Marquette University / Amy Newman, RN, MSN |
Nurse Researcher Grants |
2014 |
Wisconsin |
Optimizing Engager T-cells for CD19+ Malignancies |
Baylor College of Medicine / Mireya Paulina Velasquez, MD |
Young Investigator Grants |
2014 |
Texas |
Niche for in Vitro Generation of Hematopoietic Stem Cells from Pluripotent Stem Cells |
Fred Hutchinson Cancer Research Center / Brandon Hadland, MD, PhD |
Young Investigator Grants |
2014 |
Washington |
Neurocognitive Assessments within COG: An Intensive, Integrated Model for Successfully Evaluating Children with High-Risk ALL |
Children’s Research Institute / Kristina Hardy, PhD |
Psychosocial Grants |
2014 |
District of Columbia |
Molecular Mechanism and Development of Therapeutic Strategies Targeting MYCN-induced Calcium Signaling in Advanced Neuroblastoma |
University of Hawaii at Hilo / Ingo Koomoa-Lange, PhD |
Young Investigator Grants |
2014 |
Hawaii |